Safety and tolerability of the combination of veltuzumab and epratzumab with intensive chemotherapy in patients with relapsed B-cell acute lymphoblastic leukaemia (ALL)

2012 ◽  
Author(s):  
Joanne Meerabux
Cancers ◽  
2020 ◽  
Vol 12 (10) ◽  
pp. 2815
Author(s):  
Jacqueline A. Rehn ◽  
Matthew J. O'Connor ◽  
Deborah L. White ◽  
David T. Yeung

DUX4-rearrangement (DUX4r) is a recently discovered recurrent genomic lesion reported in 4–7% of childhood B cell acute lymphoblastic leukaemia (B-ALL) cases. This subtype has favourable outcomes, especially in children and adolescents treated with intensive chemotherapy. The fusion most commonly links the hypervariable IGH gene to DUX4 a gene located within the D4Z4 macrosatellite repeat on chromosome 4, with a homologous polymorphic repeat on chromosome 10. DUX4r is cryptic to most standard diagnostic techniques, and difficult to identify even with next generation sequencing assays. This review summarises the clinical features and molecular genetics of DUX4r B-ALL and proposes prospective new diagnostic methods.


2021 ◽  
Vol 193 (1) ◽  
pp. 171-175
Author(s):  
Stephen Fitter ◽  
Alanah L. Bradey ◽  
Chung Hoow Kok ◽  
Jacqueline E. Noll ◽  
Vicki J. Wilczek ◽  
...  

2014 ◽  
Vol 94 (2) ◽  
pp. 187-193 ◽  
Author(s):  
Mathilde Letouzey ◽  
Dominique Penther ◽  
Catherine Roche-Lestienne ◽  
Brigitte Nelken ◽  
Catherine Devoldère ◽  
...  

The Lancet ◽  
1994 ◽  
Vol 343 (8893) ◽  
pp. 331-332 ◽  
Author(s):  
W.M. Roberts ◽  
G.K. Rivera ◽  
S.C. Raimondi ◽  
V.M. Santana ◽  
J.T. Sandlund ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document